Results
3
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
3 companies
Pharma Mar
Market Cap: €1.4b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€77.40
7D
-4.4%
1Y
95.0%
Cox ABG Group
Market Cap: €880.1m
Operates as an integrated utility of water and energy company.
COXG
€11.15
7D
10.4%
1Y
n/a
Oryzon Genomics
Market Cap: €222.1m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.
ORY
€2.81
7D
-1.2%
1Y
44.5%